Showing 1-3 of 3 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Chemical ARX degraders | CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences | Stefan Kubicek | Cures | 01-June-2024 to 31-May-2026 | $199,853.60 |
| Targeting mannosylation for regenerating beta cell mass | CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences | Stefan Kubicek | Cures | 01-December-2022 to 30-November-2025 | $495,146.74 |
| Repurposing antianginal drugs for immunomodulation in Type 1 Diabetes | Medical University of Vienna | Philipp Hohensinner | Cures | 01-April-2023 to 30-September-2025 | $288,927.00 |